Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News
CABANA: Ablation surpassed drugs for raising AF quality of life
- Author:
- Mitchel L. Zoler, PhD
Publish date: January 25, 2019
News

Oncology research does crowdsourcing
- Author:
- Mitchel L. Zoler, PhD
Publish date: January 15, 2019
News

RE-SPECT ESUS: Dabigatran matched aspirin for second stroke prevention
- Author:
- Mitchel L. Zoler, PhD
Publish date: January 9, 2019
News

Biodegradable polymer shows no long-term benefit in heart stents
- Author:
- Mitchel L. Zoler, PhD
Publish date: January 9, 2019
News

New diabetes drugs solidify their cardiovascular and renal benefits
- Author:
- Mitchel L. Zoler, PhD
Publish date: January 7, 2019
News

Ticagrelor holds no edge over aspirin in CABG patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: January 4, 2019
News

Extended Holter screening finds A-fib faster after ischemic strokes
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 17, 2018
News

CABG surpasses PCI for diabetics out to 7.5 years
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 12, 2018
News

Thrombectomy shows efficacy for basilar artery strokes
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 7, 2018
News

Acute stroke thrombolysis worked safely despite GI bleed or malignancy
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 7, 2018
News
People with HIV still at increased cardiovascular risk
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 4, 2018
News

Methotrexate fails to cut CVD events in a large RCT
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 3, 2018
News

Filgotinib shows efficacy, safety in RA phase 3 and PsA phase 2 trials
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 3, 2018
News

New VTE guidelines include over 150 recommendations
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 3, 2018
Video

ARISTOPHANES: Apixaban edges other DOACS for octogenarians
- Author:
- Mitchel L. Zoler, PhD
Publish date: December 2, 2018
